[Federal Register: June 4, 1999 (Volume 64, Number 107)]
[Notices]               
[Page 30045-30046]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04jn99-89]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.
    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, New Imaging Technologies for 
Autoimmune Diseases.

[[Page 30046]]

    Date: July 16, 1999.
    Time: 8:00 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Bethesda, Maryland Room, 8120 Wisconsin Avenue, 
Bethesda, MD 20814.
    Contact Person: Anna Ramsey-Ewing, Scientific Review Administrator, 
Scientific Review Program, Division of Extramural Activities, NIAID, 
NIH, Room 2220, 6700-B Rockledge Drive, MSC 7610, Bethesda, MD 20892-
7610, 301-496-2550.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: May 28, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 99-14160 Filed 6-3-99; 8:45 am]
BILLING CODE 4140-01-M